Back to Agenda
EU Regulatory Town Hall: Stress Testing Under COVID-19 - Is the European Framework Agile Enough?
Session Chair(s)
Tony Humphreys, MPharm
Head of the Regulatory Science and Innovation Task Force
European Medicines Agency, Netherlands
The European Regulatory Town Hall will debate challenges and opportunities the European regulatory landscape is facing under COVID 19. Is the framework agile enough? How is the system addressing rapid advances in science and technology in the context of COVID 19 and how is it adapting to further enable research and development in Europe. Hear from the European Commission, the European Medicines Agency, patient representatives, EFPIA and an SME, academia, health care professionals and national competent authorities.
Speaker(s)
The Wider Picture - Communication Pharma Strategy
Andrzej Rys, MD
European Commission, European Union, Belgium
Principal Scientific Advisor
Agility of the System – the Three As: Availability, Accessibility, Affordability
Emer Cooke, MBA, MSc
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
How to Ensure That The Patient Voice is Systematically Incorporated Throughout Drug Development, Associated Evidence Generation And Decision-Making?
Marco Greco, PhD
European Patients' Forum, Belgium
President
Industry’s Vision of the Future - Innovative Pharmaceutical Environment
Nathalie Moll
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Director General
How to Support Development of Precision Medicines, Biomarkers And ‘Omics?
Ulrich Jaeger, DrMed
Medizinische Universität Wien, Austria
Professor
How To Translate Advanced Therapy Medicinal Products (ATMPS) Into Patient Treatments?
Alessandro Aiuti
San Raffaele Hospital, Italy
Clinical Research Coordinator and Head of Unit
Scientific Advice, Assessment Pathways, Optimising Evidence Including RWD For Decision Making: How To Navigate The Maze?
Yngvar P. Berg
AlgiPharma, Norway
Chief Executive Officer
How to Deal With Convergence of Technologies?
Karl Broich, DrMed
Federal Institute for Drugs and Medical Devices (BfArM), Germany
President
Have an account?